Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening

Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach Discovery of Diverse Human Dihydroorotate Dehydrogenase Inhibitors as Immunosuppressive Agents by Structure-Based Virtual Screening Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure Successful Virtual Screening for Novel Inhibitors of Human Carbonic Anhydrase:  Strategy and Experimental Confirmation Frontal Affinity Chromatography with MS Detection of EphB2 Tyrosine Kinase Receptor. 2. Identification of Small-Molecule Inhibitors via Coupling with Virtual Screening